Filing Details
- Accession Number:
- 0001225208-16-040863
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-31 16:34:28
- Reporting Period:
- 2016-10-28
- Filing Date:
- 2016-10-31
- Accepted Time:
- 2016-10-31 16:34:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1271440 | S Christopher Holland | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Senior Vice President And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-10-28 | 3,971 | $95.99 | 29,689 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-10-28 | 1,396 | $212.78 | 28,293 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-10-28 | 1,503 | $211.34 | 26,790 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-10-28 | 2,825 | $210.18 | 23,965 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2016-10-28 | 3,971 | $0.00 | 3,971 | $95.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-06-01 | No | 4 | M | Direct |
Footnotes
- Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
- Includes 80.455 shares acquired under the Company's Employee Stock Purchase Plan from May 17, 2016 to August 1, 2016.
- Represents the weighted average sales price for price increments ranging from $212.39 to $213.07. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $211.08 to $211.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Represents the weighted average sales price for price increments ranging from $210.00 to $210.41. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- Options fully vested and are currently exercisable.
Billionaire Hedge Funds
